moxifloxacin has been researched along with Meningitis, Bacterial in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heyderman, RS; McGill, F; Solomon, T | 1 |
| Albur, M; Baxter, M; Jacobson, K | 1 |
| Benjamin, DK; Cohen-Wolkowiez, M; Laughon, MM; Massaro, MM; Smith, B; Watt, KM | 1 |
| Barton, T; Bowlware, K; Hardy, RD; Iglehart, J; Katz, K; McCoig, CC; McCracken, GH; Michelow, IC; Rodriguez-Cerrato, V; Saavedra, J | 1 |
| Collignon, A; Cruaud, P; Gaudelus, J; Jacquier, H; Lachassinne, E; Poilane, I | 1 |
| Cooke, RP; Eldridge, PR; Iqbal, HJ; Kandasamy, J | 1 |
6 other study(ies) available for moxifloxacin and Meningitis, Bacterial
| Article | Year |
|---|---|
Re: Moxifloxacin should not be discounted in the treatment of bacterial meningitis.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Humans; Meningitis, Bacterial; Moxifloxacin | 2016 |
Moxifloxacin should not be discounted in the treatment of bacterial meningitis.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Humans; Meningitis, Bacterial; Moxifloxacin | 2016 |
Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Child; Child, Preschool; Doxycycline; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Pregnancy; Quinolines; Treatment Outcome | 2012 |
Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Indoles; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance | 2003 |
[In vitro activity of moxifloxacin (8-methoxyquinolone) alone or in combination with cefotaxime against group B streptococci].
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteremia; Cefotaxime; Drug Therapy, Combination; Fluoroquinolones; Humans; Infant, Newborn; Meningitis, Bacterial; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Serotyping; Streptococcal Infections; Streptococcus agalactiae | 2007 |
Primary Nocardia farcinica brain abscess with secondary meningitis and ventriculitis in an immunocompetent patient, successfully treated with moxifloxacin.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Brain Abscess; Cerebral Ventricles; Drainage; Encephalitis; Fluoroquinolones; Humans; Immunocompetence; Male; Meningitis, Bacterial; Moxifloxacin; Neurosurgical Procedures; Nocardia Infections; Occipital Lobe; Postoperative Care; Quinolines; Skull Base | 2008 |